ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,081Medicare Part D Prescriptions Filled, Including Refills

Rank: 67 out of 910

$718K Total Retail Price of All Prescriptions

Rank: 69 out of 910

756 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 756 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

9% of this provider’s 756 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

3% of this provider’s 9,412 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
LISINOPRIL 623 515 1 2
SIMVASTATIN 579 447 2 3
LEVOTHYROXINE SODIUM 573 446 3 1
ATENOLOL 362 291 4 10
OMEPRAZOLE 359 239 5 5
METFORMIN HCL 340 292 6 6
ALENDRONATE SODIUM 263 235 7 22
ZOLPIDEM TARTRATE 262 211 8 17
LOVASTATIN 260 230 9 20
METOPROLOL TARTRATE 244 190 10 7
AMLODIPINE BESYLATE 237 181 11 4
HYDROCHLOROTHIAZIDE 204 163 12 12
HYDROCODONE-ACETAMINOPHEN 181 139 S3 13 8
DIOVAN 155 138 14 34
TRAMADOL HCL 152 142 15 25
WARFARIN SODIUM 145 110 16 11
GABAPENTIN 144 102 17 13
ATORVASTATIN CALCIUM 136 125 18 14
SERTRALINE HCL 135 91 19 24
FUROSEMIDE 131 116 20 9
PRAVASTATIN SODIUM 130 105 21 16
POTASSIUM CHLORIDE 121 116 22 18
METOPROLOL SUCCINATE 121 118 22 21
CIPROFLOXACIN HCL 115 93 24 48
CITALOPRAM HBR 112 73 25 19
DICLOFENAC SODIUM 104 91 26 116
PROAIR HFA 103 52 27 40
GLYBURIDE 96 63 R 28 46
FLUOXETINE HCL 96 74 28 49
HYDRALAZINE HCL 95 80 30 65
VYTORIN 94 77 31 82
OXYBUTYNIN CHLORIDE 91 66 32 83
GLIMEPIRIDE 87 69 33 56
TRIAMTERENE-HCTZ 87 86 33 39
GEMFIBROZIL 84 48 35 63
RANITIDINE HCL 80 60 36 28
NIFEDIPINE ER 79 73 37 107
PANTOPRAZOLE SODIUM 79 61 37 27
TAMSULOSIN HCL 74 74 39 29
PAROXETINE HCL 73 54 40 50
FLUTICASONE PROPIONATE 72 52 41 23
TRAZODONE HCL 68 37 42 37
ALLOPURINOL 67 67 43 33
ADVAIR DISKUS 64 37 44 45
OXYCODONE-ACETAMINOPHEN 64 40 S2 44 31
PREMARIN 63 63 R 46 127
LEVOFLOXACIN 63 52 46 110
ESTRADIOL 62 38 R 48 92
ZETIA 59 49 49 84
CRESTOR 57 49 50 26
LOSARTAN POTASSIUM 57 57 50 15
AMITRIPTYLINE HCL 56 33 R 52 72
CLOPIDOGREL 54 34 53 35
ACTONEL 52 33 54 102
JANUVIA 51 51 55 69
CARISOPRODOL 51 43 R 55 71
AMOX TR-POTASSIUM CLAVULANATE 51 39 55 125
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 14, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.